Vadodara-based Sudeep Pharma files draft papers with SEBI for an IPO, aiming to raise funds through fresh issuance and offer ...

The IPO comprises a fresh issue worth Rs 95 crore and an offer for sale (OFS) of up to 1,00,76,492 equity shares by the ...

Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

As part of celebrating WWMT's 75th birthday, we're catching up with some of the people who have been part of television ...

We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

Total construction starts were up 13% in May to a seasonally adjusted annual rate of $1.16 trillion, according to Dodge ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...